Terms: = Brain cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
1116 results:
1. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules.
Bibbò F; Asadzadeh F; Boccia A; Sorice C; Bianco O; Saccà CD; Majello B; Donofrio V; Bifano D; De Martino L; Quaglietta L; Cristofano A; Covelli EM; Cinalli G; Ferrucci V; De Antonellis P; Zollo M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612726
[TBL] [Abstract] [Full Text] [Related]
2. Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of pten to induce an aggressive glioma phenotype.
Nuechterlein N; Shelbourn A; Szulzewsky F; Arora S; Casad M; Pattwell S; Merino-Galan L; Sulman E; Arowa S; Alvinez N; Jung M; Brown D; Tang K; Jackson S; Stoica S; Chittaboina P; Banasavadi-Siddegowda YK; Wirsching HG; Stella N; Shapiro L; Paddison P; Patel AP; Gilbert MR; Abdullaev Z; Aldape K; Pratt D; Holland EC; Cimino PJ
Genes Dev; 2024 Apr; 38(5-6):273-288. PubMed ID: 38589034
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the pten/PI3K/AKT/NF-κB pathway.
Kim MJ; Lim SG; Cho DH; Lee JY; Suk K; Lee WH
Biochem Biophys Res Commun; 2024 May; 709():149828. PubMed ID: 38537596
[TBL] [Abstract] [Full Text] [Related]
4. Reactivating pten to impair glioma stem cells by inhibiting cytosolic iron-sulfur assembly.
Yin J; Ge X; Ding F; He L; Song K; Shi Z; Ge Z; Zhang J; Ji J; Wang X; Zhao N; Shu C; Lin F; Wang Q; Zhou Q; Cao Y; Liu W; Ye D; Rich JN; Wang X; You Y; Qian X
Sci Transl Med; 2024 Mar; 16(739):eadg5553. PubMed ID: 38507470
[TBL] [Abstract] [Full Text] [Related]
5. Cerebellar phenotypes in germline pten mutation carriers.
Gambini D; Ferrero S; Bulfamante G; Pisani L; Corbo M; Kuhn E
Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12970. PubMed ID: 38504418
[TBL] [Abstract] [Full Text] [Related]
6. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
8. brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract] [Full Text] [Related]
9. Tumorigenesis of basal muscle invasive bladder cancer was mediated by pten protein degradation resulting from SNHG1 upregulation.
Li T; Huang M; Sun N; Hua X; Chen R; Xie Q; Huang S; Du M; Zhao Y; Lin Q; Xu J; Han X; Zhao Y; Tian Z; Zhang Y; Chen W; Shen X; Huang C
J Exp Clin Cancer Res; 2024 Feb; 43(1):50. PubMed ID: 38365726
[TBL] [Abstract] [Full Text] [Related]
10. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
[TBL] [Abstract] [Full Text] [Related]
11. The genomic alterations in glioblastoma influence the levels of CSF metabolites.
Wang DH; Fujita Y; Dono A; Rodriguez Armendariz AG; Shah M; Putluri N; Pichardo-Rojas PS; Patel CB; Zhu JJ; Huse JT; Parker Kerrigan BC; Lang FF; Esquenazi Y; Ballester LY
Acta Neuropathol Commun; 2024 Jan; 12(1):13. PubMed ID: 38243318
[TBL] [Abstract] [Full Text] [Related]
12. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with pten hamartoma tumor syndrome.
Liu D; Yehia L; Dhawan A; Ni Y; Eng C
Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
[TBL] [Abstract] [Full Text] [Related]
13. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J; Natsumeda M; Takahashi H; Koyama A; Shibuma S; Shibata N; Watanabe J; Saito S; Kanemaru Y; Tsukamoto Y; Okada M; Ogura R; Eda T; Tada M; Shimizu H; Adachi JI; Mishima K; Nishikawa R; Kakita A; Oishi M
J Neurooncol; 2024 Jan; 166(2):273-282. PubMed ID: 38227143
[TBL] [Abstract] [Full Text] [Related]
14. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
Mohajerani F; Tehrankhah ZM; Rahmani S; Afsordeh N; Shafiee S; Pourgholami MH; Soltani BM; Sadeghizadeh M
BMC Cancer; 2024 Jan; 24(1):19. PubMed ID: 38167030
[TBL] [Abstract] [Full Text] [Related]
15. nSEA: n-Node Subnetwork Enumeration Algorithm Identifies Lower Grade Glioma Subtypes with Altered Subnetworks and Distinct Prognostics.
Zhang Z; Wang C; Zhao Z; Yi Z; Durmaz A; Yu JS; Bebek G
Pac Symp Biocomput; 2024; 29():521-533. PubMed ID: 38160304
[TBL] [Abstract] [Full Text] [Related]
16. pten-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells.
Wang S; Riedstra CP; Zhang Y; Anandh S; Dudley AC
Br J Cancer; 2024 Mar; 130(4):555-567. PubMed ID: 38148377
[TBL] [Abstract] [Full Text] [Related]
17. A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules.
Iragavarapu-Charyulu V; Shakya R; Robinson P; Guzmán E; Tyulmenkova A; Pino JL; Isgor C
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131223
[TBL] [Abstract] [Full Text] [Related]
18. Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain.
Sabattini S; Baldassarro VA; Zaccone R; Calzà L; Giardino L; Vascellari M; Lorenzini L; Moretti M; Marconato L
Vet Comp Oncol; 2024 Mar; 22(1):70-77. PubMed ID: 38112225
[TBL] [Abstract] [Full Text] [Related]
19. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence.
Olatunji G; Aderinto N; Adefusi T; Kokori E; Akinmoju O; Yusuf I; Olusakin T; Muzammil MA
Medicine (Baltimore); 2023 Dec; 102(48):e36421. PubMed ID: 38050252
[TBL] [Abstract] [Full Text] [Related]
[Next]